JANX vs TFX · rev $10.3M vs P/E 2083, rev $1.12B
Janux Therapeutics Inc (JANX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
JANX currently screens at market cap $1.49B. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the JANX and TFX stock pages for the full models.
Not investment advice.